Adaptive Biotechnologies Corp (ADPT) Stock Analysis

Adaptive Biotechnologies Corp (ADPT) is a publicly traded company in the HEALTHCARE sector. It trades at $17.07, carries a market capitalization of $2.78B. This page summarizes the public market data, fundamentals, and frequently asked questions for ADPT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $17.07
• Market Cap: $2.78B
• EPS: $-0.32
• 52-Week High: $20.76
• 52-Week Low: $9.90

Market Sentiment

Adaptive Biotechnologies Corp currently has a Neutral sentiment score of -0.01.

GNG Research Analysis

GNG Research scores Adaptive Biotechnologies Corp (ADPT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ADPT.

Frequently Asked Questions

Does ADPT pay dividends?

Adaptive Biotechnologies Corp (ADPT) does not currently pay a regular dividend.

What is ADPT's market cap?

Adaptive Biotechnologies Corp (ADPT) has a market capitalization of $2.78B with a current stock price of $17.07.